Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Joseph Debono"'
Autor:
Dibbendhu Khanra, Anindya Mukherjee, Anunay Gupta, Atif Muhammad Rauf, Bhanu Duggal, Bode Ensam, Manish Kalla, Joseph DeBono, Mauro Lencioni, Howard Marshall
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 24, Iss 4, Pp 183-188 (2024)
Background: Atrial fibrillation (AF) ablation can lead to oesophageal thermal injuries (ETI). These are thought to be the precursor of the much rarer but frequently fatal atrio-oesophageal fistulas. Many centers performing AF ablation routinely use o
Externí odkaz:
https://doaj.org/article/cd29e5dc79914cc4aeda4f0f253f0414
Autor:
Otilia Țica, Ovidiu Țica, Karina V. Bunting, Joseph deBono, Georgios V. Gkoutos, Mircea I. Popescu, Dipak Kotecha
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background The prevalence of combined heart failure (HF) and atrial fibrillation (AF) is rising, and these patients suffer from high rates of mortality. This study aims to provide robust data on factors associated with death, uniquely suppor
Externí odkaz:
https://doaj.org/article/c5ad3d6dc08846ec892e7f3f87d82a4e
Autor:
John Paul Cauchi, Maria-Louise Borg, Aušra Džiugytė, Jessica Attard, Tanya Melillo, Graziella Zahra, Christopher Barbara, Michael Spiteri, Allan Drago, Luke Zammit, Joseph Debono, Jorgen Souness, Steve Agius, Sharon Young, Alan Dimech, Ian Chetcuti, Mark Camenzuli, Ivan Borg, Neville Calleja, Lorraine Tabone, Charmaine Gauci, Pauline Vassallo, Joaquin Baruch
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 12, p e37669 (2022)
BackgroundIn late 2020, the European Centre for Disease Prevention and Control and Epiconcept started implementing a surveillance system for severe acute respiratory infections (SARI) across Europe. ObjectiveWe sought to describe the process of digi
Externí odkaz:
https://doaj.org/article/c592b7461e634f7380217db9e1a865a2
Publikováno v:
The Surgery Journal, Vol 05, Iss 04, Pp e150-e153 (2019)
Introduction The Littre hernia is a rare complication of Meckel's diverticulum. Meckel's diverticulum is vestigial remnant of the omphalomesenteric duct occurring in approximately 2% of the general population with an estimated 4 to 16% risk of compli
Externí odkaz:
https://doaj.org/article/facd757bc21c4a4e8b48f702c8481f7f
Autor:
T. Qiu, Abbasin Zegard, Manish Kalla, Lucy Hudsmith, Osita Okafor, Richard P. Steeds, Berthold Stegemann, Joseph DeBono, Francisco Leyva, Howard Marshall, M Lencioni
Publikováno v:
Journal of the American College of Cardiology. 77:29-41
Funding Acknowledgements Type of funding sources: None. BACKGROUND The ‘grayzone’ of myocardial fibrosis (GZF) on cardiovascular magnetic resonance may be a substrate for ventricular arrhythmias (VAs). OBJECTIVES To determine whether GZF predicts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df53683fc0baf11cdb470f77c2942fb
https://doi.org/10.1016/j.jacc.2020.10.046
https://doi.org/10.1016/j.jacc.2020.10.046
Autor:
John Paul Cauchi, Maria-Louise Borg, Ausra Dziugyte, Jessica Attard, Tanya Melillo, Graziella Zahra, Christopher Barbara, Michael Spiteri, Allan Drago, Luke Zammit, Joseph Debono, Jorgen Souness, Steve Agius, Sharon Young, Alan Dimech, Ian Chetcuti, Mark Camenzuli, Ivan Calleja, Neville Calleja, Lorraine Tabone, Charmaine Gauci, Joaquin Baruch
BACKGROUND Background: In late 2020, the European Centre for Disease Prevention and Control and Epiconcept started implementing a surveillance system for severe acute respiratory infections (SARI) across Europe. Our objective is to describe how SARI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51bc4de246c5f4b1d93ebe8bfdab8ab
https://doi.org/10.2196/preprints.37669
https://doi.org/10.2196/preprints.37669
Abstract P2-08-13: Genetic testing for breast cancer and associated downstream utilization and costs
Publikováno v:
Cancer Research. 80:P2-08
Background: Given the clinical utility for diagnosis and treatment of hereditary breast cancer, the use of genetic testing is growing. However, few data exist on the association between genetic testing and subsequent clinical outcomes, healthcare uti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72271a1873c18e8d35e4fca673e15ad2
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-13
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-13
Autor:
Collin Churchill, Mukul Singhal, Michael J. Fisch, Bal Nepal, Judith J. Stephenson, David Joseph Debono, Amy R Geschwender, Keri Stenger, Gregory L Price, Michael Grabner, Gebra Cuyun Carter, Rebekah Zincavage, Emily Zhu, J. Gable
Publikováno v:
Patient preference and adherence
Judith J Stephenson,1 Jonathon Colby Gable,2 Rebekah Zincavage,1 Gregory L Price,2 Collin Churchill,2 Emily Zhu,2 Keri Stenger,2 Mukul Singhal,1 Bal Nepal,1 Michael Grabner,1 Michael J Fisch,3 David Debono,4 Amy R Geschwender,5 Gebra Cuyun Carter2 1H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ce582f023e8504cba740c2c13b397f
https://www.dovepress.com/treatment-experiences-with-cdk46-inhibitors-among-women-with-metastati-peer-reviewed-fulltext-article-PPA
https://www.dovepress.com/treatment-experiences-with-cdk46-inhibitors-among-women-with-metastati-peer-reviewed-fulltext-article-PPA
Autor:
Samyukta Mullangi, Xiaoxue Chen, Timothy Pham, Ying Liu, Aliza Gordon, David Joseph Debono, Michael Jordan Fisch, Mithat Gonen, Dawn L. Hershman
Publikováno v:
Journal of Clinical Oncology. 40:7-7
7 Background: Rising healthcare costs have garnered interest from payers in shifting oncology care towards a value-based practice model. Pathways are a subset of evidence-based guidelines designed to standardize cancer drug prescribing by clarifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cacc417901fcf64b752d4f7834f2cde7
https://doi.org/10.1200/jco.2022.40.28_suppl.007
https://doi.org/10.1200/jco.2022.40.28_suppl.007
Publikováno v:
Journal of Clinical Oncology. 40:398-398
398 Background: Between March 2017 and May 2020, ten new systemic medication therapies for hepatocellular carcinoma (HCC) were approved for the US market. However, clinical trials for medications only showed marginal improvement in health outcomes co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a758ea4b5a0d35ce6917d6aefbd7d7cf
https://doi.org/10.1200/jco.2022.40.28_suppl.398
https://doi.org/10.1200/jco.2022.40.28_suppl.398